Apogee Therapeutics, Inc. Common Stock (APGE) Insider Trading
- $29,750,000.00
- $7,842,946.75
- Oct. 2, 2024
- Carl Dambkowski
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Oct. 2, 2024 | Insider | 6,665 | $56.26 | Sell | $374,972.90 | |
| Oct. 2, 2024 | CEO | 40,000 | $56.23 | Sell | $2,249,200.00 | |
| Sept. 4, 2024 | CEO | 40,000 | $47.62 | Sell | $1,904,800.00 | |
| Sept. 4, 2024 | Insider | 6,665 | $47.56 | Sell | $316,987.40 | |
| Aug. 23, 2024 | CFO | 6,000 | $48.26 | Sell | $289,560.00 | |
| Aug. 7, 2024 | Insider | 7,335 | $40.67 | Sell | $298,314.45 | |
| Aug. 7, 2024 | CEO | 40,000 | $40.62 | Sell | $1,624,800.00 | |
| July 5, 2024 | CEO | 15,000 | $37.26 | Sell | $558,900.00 | |
| July 3, 2024 | Insider | 5,995 | $37.60 | Sell | $225,412.00 | |
| July 13, 2023 | Director | 1,750,000 | $17.00 | Buy | $29,750,000.00 |
Insiders are both buying and selling Apogee Therapeutics, Inc. Common Stock stock.
The insider traders at Apogee Therapeutics, Inc. Common Stock are: Carl Dambkowski, Michael Thomas Henderson, Jane Henderson, and Nimish P Shah
The most active insider trader at Apogee Therapeutics, Inc. Common Stock is Carl Dambkowski with 4 trades.
Michael Thomas Henderson has sold the most Apogee Therapeutics, Inc. Common Stock stock with a total value of $8,586,900.00.
Nimish P Shah has bought the most Apogee Therapeutics, Inc. Common Stock stock with a total value of $59,500,000.00.
The most recent insider trade for Apogee Therapeutics, Inc. Common Stock was on Oct. 2, 2024.
The single biggest insider buy for Apogee Therapeutics, Inc. Common Stock was from Nimish P Shah with a total value of $29,750,000.00 on July 13, 2023.
The single biggest insider sell for Apogee Therapeutics, Inc. Common Stock was from Michael Thomas Henderson with a total value of $2,249,200.00 on Oct. 2, 2024.